"Patients come to Northshore Oncology Associates for comprehensive medical care in a state-of-the-art, patient-centered environment that cares for them from diagnosis, during and after treatment"

During the past decade, Northshore Oncology Associates-Covington conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 10 clinical trials were completed, i.e. on average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 10 clinical trials were completed. i.e. 76.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northshore Oncology Associates-Covington" #1 sponsor was "National Cancer Institute (NCI)" with 24 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "SWOG Cancer Research Network" with 7 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored and "NRG Oncology" with 5 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northshore Oncology Associates-Covington" #1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Northshore Oncology Associates-Covington" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Breast Carcinoma" (3 trials), "Estrogen Receptor Negative" (3 trials) and "HER2/Neu Negative" (3 trials). Many other conditions were trialed in "Northshore Oncology Associates-Covington" in a lesser frequency.

Most popular intervention types in "Northshore Oncology Associates-Covington" are "Other" (36 trials), "Drug" (34 trials), "Biological" (21 trials), "Procedure" (19 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (19 trials), "Biospecimen Collection" (14 trials), "Computed Tomography" (14 trials), "Nivolumab" (12 trials) and "Questionnaire Administration" (12 trials). Other intervention names were less common.

The vast majority of trials in "Northshore Oncology Associates-Covington" are 45 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Northshore Oncology Associates-Covington". undefined are not yet recruiting, 15 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Northshore Oncology Associates-Covington, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Northshore Oncology Associates-Covington, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".